Quick Summary
Tafmune EM Tablet
Last updated on 21 Aug 2026 | 06:01 AM (IST)
₹1160
MRP: ₹2108.87
(You Save ₹948.87)
30 TABLET(s) IN A BOTTLE
45% OFF
₹1160
MRP: ₹2,108.87
Inclusive of all taxes
45% Off
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
Tafero EM Tablet
HETERO HEALTHCA...
₹ 48.57/tablet
26% costlier
Emtaf Tablet
EMCURE PHARMACE...
₹ 52.07/tablet
35% costlier
Taficita Tablet
MYLAN PHARMACEU...
₹ 36.67/tablet
5% cheaper


Introduction
Tafmune EM Tablet contains the active ingredient Emtricitabine/ tenofovir alafenamide. It is a combination of antiretroviral medication. Emtricitabine belongs to the class of medication called nucleoside reverse transcriptase inhibitor (NRTI), and tenofovir alafenamide belongs to the class called nucleotide reverse transcriptase inhibitor (NtRTI). It is used in combination with other medicines to treat human immunodeficiency virus (HIV-1) infection in adults and adolescents 12 years of age and who weigh at least 35kg. They work by slowing the spread of HIV in the body.
Do not take Tafmune EM Tablet if you are allergic to Emtricitabine/ tenofovir alafenamide or any of the other ingredients. Get tested for HIV infection regularly while using this medicine. Do not miss any doses of this medicine or stop taking it. Missing doses may increase your risk of getting HIV infection. This medicine does not prevent other sexually transmitted infections (STIs). Inform your physician if you have liver problems or suffer from liver disease, including hepatitis, kidney problems, and bone problems. Do not give this medicine to children aged 11 years or under.
Uses
- HIV infection
How Tafmune EM Tablet works
Emtricitabine and tenofovir alafenamide are nucleoside/nucleotide analog reverse transcriptase inhibitors, exhibiting their antiviral effect by competing with natural substrates and incorporating them into viral DNA, resulting in the termination of the DNA chain.
Interaction of Tafmune EM Tablet with other drugs
Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional and vitamin supplements, and herbal products. Certain medications interact with Tafmune EM Tablet and reduce its effectiveness by causing undesirable side effects.
Storage conditions
-
Store Tafmune EM Tablet below 30°C
-
Protect the medicine from light and excessive moisture.
-
Keep the medicine out of reach of children and pets
-
If you forgot to take the tablet, take your next dose at the scheduled time. Do not take a double dose to make up for a forgotten dose.
How to take Tafmune EM Tablet
It is an orally available prescription drug. Your doctor will decide the dose and duration of Tafmune EM Tablet based on the disease condition and other factors such as body weight and age. Always take this medicine as prescribed by your doctor. Take the tablet at the same time, with or without food. Do not break, chew, crush, or break the tablet. Swallow the whole tablet with a glass of water. If you have difficulty in swallowing the tablet whole, you can split it in half after consulting with your doctor.
Safety Advices
Pregnancy
There is limited information on the use of Tafmune EM Tablet during pregnancy. Inform your physician if you are pregnant or planning to get pregnant during the treatment.
Breast Feeding
Breastfeeding is not recommended in patients taking Tafmune EM Tablet because the medicine passes into the breast milk in small amounts and may harm your baby. Do not breastfeed during the treatment.
Lungs
It is unknown whether Tafmune EM Tablet is safe to be administer in patients with lung diseases. Inform your physician if you have any lung diseases before initiating the therapy.
Liver
Tafmune EM Tablet should be cautiously administered in patients with liver diseases. Dose adjustments are necessary. However, inform your physician if you have any liver diseases before initating the therapy.
Alcohol
It is unsafe to drink alcohol while taking Tafmune EM Tablet. It may reduce the effectiveness of the drug and can cause toxic side effects.
Driving
Tafmune EM Tablet can cause dizziness. It is recommended to avoid driving and operating heavy machinery during the treatment.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Serious
-
Hepatitis B reactivation
-
Increased risk of fracture
-
Acute renal failure
Common
-
Nausea, vomiting
Expert Tips
-
Take the medicine exactly as prescribed — do not skip doses or stop without your doctor’s advice.
-
Always take it with food to reduce nausea and vomiting.
-
Do not take more than the recommended dose or change it without consulting your doctor.
-
Continue using all HIV medications in your combination therapy as directed.
-
Practice safe sex and avoid sharing needles to prevent spreading or worsening the infection.
FAQs
Q1.
Can Tafmune EM Tablet cure HIV?
Tafmune EM Tablet is not a cure for HIV. It is an antiretroviral medication that helps control the virus, reduce its replication, and slow down the progression of the disease. It is essential to continue taking the medication as prescribed, even if you feel well, to maintain viral suppression and protect your immune system.
Q2.
What should I do if I miss a dose of Tafmune EM Tablet?
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one. It is important to speak with your healthcare provider if you frequently miss doses or have difficulty adhering to the medication schedule.
Q3.
Does Tafmune EM Tablet interact with grapefruit or grapefruit juice
No known interactions exist between Tafmune EM Tablet and grapefruit or grapefruit juice. However, discussing any dietary concerns or potential interactions with your healthcare provider is always a good idea.
Q4.
Does Tafmune EM Tablet affects the liver?
People with liver disease, including chronic hepatitis B or C taking antiretrovirals have a higher risk of severe and potentially fatal liver complications. If you have hepatitis B infection, your doctor will carefully consider the best treatment regimen for you
Q5.
Can women use Tafmune EM Tablet?
The use of Tab Tafero EM 10 to reduce the risk of getting HIV infection in women has not been well established. Consult your doctor before taking this medicine if you are a woman.
Fact Box
|
Molecule name: |
Emtricitabine/Tenofovir Alafenamide |
|
Pharmacological class: |
Nucleoside/Nucleotide reverse transcriptase inhibitors |
|
Therapeutic class: |
Anti-retroviral |
|
Indications |
HIV infection |
References
-
Descovy 200 mg/25 mg film coated tablets - Summary of Product Characteristics (SmPC) - (emc). www.medicines.org.uk. Published April 2022. Accessed May 20, 2023. https://www.medicines.org.uk/emc/product/2108/smpc
-
Emtricitabine / Tenofovir Alafenamide - Patient | NIH. clinicalinfo.hiv.gov. Published February 27, 2023. Accessed May 20, 2023. https://clinicalinfo.hiv.gov/en/drugs/emtricitabine-tenofovir-alafenamide/patient#dr1
-
KD Tripathi, Antiviral Drugs (Anti-retrovirus), Essentials of Medical Pharmacology, 8th Edition, 2019, 860-872.
-
Gilead Sciences, Inc., US Food & Drug Administration, [Revised on Sep 2017] [Accessed on 14th Aug 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208215s005lbl.pdf
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details

Written By
Dr. Vikas B S
Pharm D

Reviewed By
Dr. Abhishaanth Prabu
MBBS
Last updated : 21 Aug 2026 | 06:01 AM (IST)

Want to know more?
Read Our Editorial Policy








